Quick Answer
Taysha Gene Therapies, Inc. reported Total Assets of $343.32 million for fiscal year 2025.
Taysha Gene Therapies, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $343.32M | +114.1% |
| 2024 | $160.36M | -7.2% |
| 2023 | $172.73M | +36.8% |
| 2022 | $126.28M | -41.0% |
| 2021 | $213.96M | -17.4% |
| 2020 | $258.88M | +1725773.3% |
| 2019 | $15.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $316.55M | +75.7% | -5.0% |
| June 30, 2025 | $333.33M | +66.3% | +140.9% |
| March 31, 2025 | $138.36M | -9.6% | -13.7% |
| December 31, 2024 | $160.36M | -7.2% | -11.0% |
| September 30, 2024 | $180.22M | -7.9% | -10.1% |
| June 30, 2024 | $200.39M | +145.8% | +31.0% |
| March 31, 2024 | $153.00M | +50.6% | -11.4% |
| December 31, 2023 | $172.73M | +36.8% | -11.8% |
- Taysha Gene Therapies, Inc. showed an increase of +114.1% in Total Assets compared to the prior fiscal year.
- Over the 2019–2025 period, Taysha Gene Therapies, Inc.’s total assets has grown by 2288700.0% (from $15.0 thousand to $343.32 million).
- The most recent figure is from Taysha Gene Therapies, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: